A cohort study illustrated that biomarker of neuroinflammation in the CSF such as IL‐6, IL‐15 and MCP‐1 are increased in AD patients with cognitive impairment compared to AD without cognitive impairment.108. Here, CCL2 is linked to Cognitive impairment.